Dan Schoen Email and Phone Number
Dan Schoen work email
- Valid
- Valid
Dan Schoen personal email
- Valid
With nearly two decades in biopharmaceuticals, I specialize in shaping global market access strategies to optimize revenue and ensure patient access to transformative therapies. Currently, as Director TTR Franchise at Alnylam Pharmaceuticals (and Regional Access Lead for Partner Markets), I lead pricing and reimbursement strategies for Onpattro and Amvuttra, focusing on expanding indications and maximizing market entry effectiveness, with a keen focus on our initial launch into Cardiomyopathy.Previously at AbbVie, I led launch strategies for Teliso-V in NSCLC as the Oncology Market Access c-MET Franchise Lead. I excel in developing integrated access plans and business assessments that accelerate market adoption and enhance competitive positioning.My career spans strategic roles in global market access and pricing within oncology, immunology, and specialty/rare disease, emphasizing my ability to navigate complex market landscapes and drive revenue growth through innovative access strategies. I bring a proven track record in strategic leadership and cross-functional collaboration, essential for achieving market leadership in biopharmaceuticals.ROBUST EXPERTISEStrategic Pricing ▪ Market Access Strategy ▪ Product Launch Planning ▪ International Reference Pricing ▪ Value-based Pricing ▪ Contracting Strategy ▪ Cross-functional Leadership ▪ Revenue Optimization ▪ Financial Acumen ▪ Competitive Intelligence Analysis ▪ Stakeholder Management ▪ Market Segmentation ▪ Pricing Governance ▪ Healthcare Policy Analysis ▪ Commercial Strategy Development
Alnylam Pharmaceuticals
View- Website:
- alnylam.com
- Employees:
- 1542
-
Director Ttr Franchise, Global Market Access And PricingAlnylam Pharmaceuticals Jun 2022 - PresentChicago/CambridgeI lead pricing and reimbursement strategies globally for Onpattro and Amvuttra, focusing particularly on the cardiomyopathy launch and expanding franchise indications, while providing critical access insights into pipeline development. I collaborate extensively across functions to develop and implement pricing strategies and launch sequencing, representing market access on the TTR leadership team and providing critical insights and strategic direction.Key Accomplishments:➛ Spearheaded the development and implementation of the first integrated access strategy at Alnylam for the TTR franchise, transforming our approach to market access.➛ Established pricing policy and guidance governance, improving efficiency and clarity in pricing strategies organization-wide.➛ Led the long-range planning process for global market access, offering vital insights and strategic direction for future initiatives.➛ Successfully negotiated pricing and access agreements in partner and emerging markets, optimizing market entry and ensuring competitive pricing for TTR franchise products.➛ Presented portfolio analysis insights at an executive level, influencing decision-making processes and shaping strategic directions for future initiatives.
-
Oncology Market Access C-Met Franchise Lead – Global Market Access & PricingAbbvie Jan 2022 - Jun 2022Chicago, Illinois, United StatesI led the c-MET franchise at AbbVie, overseeing three pipeline assets, including Teliso-V in NSCLC, which will hopefully be AbbVie's inaugural solid tumor launch. In this role, I established and led the Value and Access Teams, responsible for developing integrated access strategies for each asset and the overall franchise. I directed solid tumor business development assessments, guiding strategic decisions aligned with franchise objectives. I played a crucial role in shaping trial designs to optimize access and pricing strategies, navigating through various market complexities.Key Accomplishments:➛ Successfully advanced the c-MET franchise within the challenging landscape of NSCLC.➛ Fostered a positive team environment, ensuring high morale and sustained focus on strategic objectives.➛ Contributed significantly to the development of an integrated access strategy, enabling optimal market entry for pipeline assets. -
Associate Director, Global Market Access - Lifecycle Strategy Lead, VenetoclaxAbbvie Mar 2020 - Dec 2021Chicago, Illinois, United StatesI oversaw the lifecycle strategy for Venetoclax at AbbVie, focusing on launch planning for Mantle Cell Lymphoma and renegotiations for r/r CLL indications. My role involved developing orphan strategies across various indications to ensure strategic market entry. I was responsible for managing LOE pricing strategy and solid tumor access plans for Venetoclax, providing strategic direction within the Global Brand Team (GBT) framework.Key Accomplishments:➛ Successfully executed launch strategies for Mantle Cell Lymphoma and r/r CLL, driving substantial market adoption.➛ Developed and implemented orphan strategies, effectively optimizing market access strategies while preserving asset value.➛ Implemented impactful LOE pricing strategies and solid tumor access plans, maximizing revenue potential and enhancing market presence.
-
Associate Director, Oncology Pricing - Global Market AccessAbbvie Jan 2018 - Mar 2020Chicago, Illinois, United StatesI managed global price bands, launch sequencing, and International Reference Pricing (IRP) impacts for AbbVie's Hematology franchise, focusing on Venetoclax and Navitoclax. I led the launch efforts for Venetoclax, overseeing strategies for both monotherapy and combination therapy. My role included conducting lifecycle planning and indication sequencing, ensuring strategic alignment pre and post Loss of Exclusivity (LOE). I maintained expertise in payer environments across major markets, with a particular emphasis on Oncology coverage, reimbursement, pricing, Health Technology Assessment (HTA), and healthcare policy. I presented complex pricing analyses bi-weekly to the Chief Commercial Officer, translating insights into actionable strategies. Additionally, I developed innovative contracting concepts for execution at the affiliate level, addressing complexities in combination pricing and value differentiation.Key Accomplishments:➛ Launched Venetoclax successfully as both monotherapy and combination therapy, demonstrating strategic agility and adaptability.➛ Earned multiple prestigious awards, including President's Awards and Best-in-Class Awards, for outstanding performance in pricing and reimbursement strategy.➛ Implemented innovative contracting concepts that drove record achievements in pricing and reimbursement, enhancing AbbVie's competitive positioning in challenging markets.
-
Sr. Manager, Immunology Pricing - Global Market AccessAbbvie Jan 2015 - Dec 2017ChicagoProvided vision and pricing insights for Humira and biosimilars, contributing to strategic pricing strategies pre and post loss of exclusivity. Recognized with a President's Award for impactful contributions to pricing strategy.
-
Finance Manager, Global Supply ChainBaxter International Inc. Jul 2014 - Jan 2015Chicago, Illinois, United StatesManaged $900M P&L expenses and $1B inventory, supporting operational planning and deployment. Led financial analysis and strategic decision-making for market demand fluctuations. -
Finance ManagerAbbott Oct 2006 - Jul 2014ChicagoGuided financial support and insights for Abbott Nutrition Supply Chain operations. Led volume alignment efforts across Supply Chain and Commercial functional areas, optimizing planning processes.Finance Manager, Nutrition Supply ChainSr. Analyst, Long Range Planning (Nutrition International)FP&A Manager, Colombian Affiliate (Nutrition International)Sr. FP&A Analyst (Nutrition International)Cost Analyst, Corporate Manufacturing Accounting -
Business Development RepresentativeBank Of America Aug 2005 - Oct 2006San Francisco Bay AreaAnalyzed financial statements for businesses, supervised business bankers, and achieved top ranking in Northern California division for sales performance.
Dan Schoen Skills
Dan Schoen Education Details
-
Master Of Business Administration - Mba -
Finance, General -
Electrical And Electronics Engineering
Frequently Asked Questions about Dan Schoen
What company does Dan Schoen work for?
Dan Schoen works for Alnylam Pharmaceuticals
What is Dan Schoen's role at the current company?
Dan Schoen's current role is Global Market Access Strategy Leader | Driving Revenue Growth & Market Expansion | Expert in Pharmaceutical Market Access.
What is Dan Schoen's email address?
Dan Schoen's email address is ds****@****ail.com
What schools did Dan Schoen attend?
Dan Schoen attended Lake Forest Graduate School Of Management, Michigan State University - Eli Broad College Of Business, University Of Michigan College Of Engineering.
What skills is Dan Schoen known for?
Dan Schoen has skills like Forecasting, Financial Modeling, Finance, Management, Financial Reporting, Financial Analysis, Analysis, Auditing, Financial Planning, Strategic Financial Planning, Sap, Variance Analysis.
Who are Dan Schoen's colleagues?
Dan Schoen's colleagues are Liesbeth Mickenautsch - Van De Laar, Cortney Johnson, Joachim Le Garrec, Pharmd, Sabrina Belozerova, Kirsten Deprey, Eva Houser, Pharmd, Nicholas Taylor.
Not the Dan Schoen you were looking for?
-
1metrixco.com2 +156355XXXXX
-
2gmail.com, gkitchens.com9 +131232XXXXX
-
Dan Schoen
Santa Monica, Ca5gmail.com, telaria.com, sizmek.com, majority.co, magnite.com4 +121542XXXXX
-
Dan Schoen
St Louis, Mo3bsci.com, bostonscientific.com, bsci.com1 +150868XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial